Jump to content

Talk:Evidence-based assessment/Attention deficit hyperactivity disorder (assessment portfolio)

Page contents not supported in other languages.
Add topic
From Wikiversity
< Talk:Evidence-based assessment
Latest comment: 2 years ago by Hope Holloway in topic Summer 2022 Audit

ADHD in Adults

[edit source]

This is a topic that definitely needs attention. Per conversations with John Rush, there is a high level decision about whether adult versus youth assessment should be split into separate pages.

Even with that up for discussion, there is a need to gather resources for adult assessment. Here's a start of a few to consider:

ASRS v1.1 was developed by Kessler and co. with the copyright assigned to the World Health Organization. Here's a link to the page for it at Harvard. The open questions with it include:

  1. Is there a collateral/other report version?
  2. Are there better norms than the 2005 estimate on that site (which was a weighted estimate using a clinical sample)?
  3. Any information about sensitivity to treatment effects?
  4. Has anyone ROCed it against the NCS-R or other structured diagnostic interviews?
    1. The anchor publication[1] presents ROC results in Table 2.
    2. Ustun et al. 2017 create a short form of the DSM-5 version.
    3. There is a Spanish translation validated by Richarte et al. 2017.[2]

The CADDRA website is a Canadian nonprofit organization that has a set of several interesting measures on it, including two by M.D. Weiss that were new to me (the second being a very detailed functioning one), as well as some prototype clinical transfer forms that could be interesting models. Open questions here:

  1. Has Weiss published any research on these?
    1. If not, any data?
    2. Any interest in sharing?
  2. What do expert clinicians think of the medication form, the transfer form, etc?


The CHADD website lists several tools, including a DSM-5 version of the 6 item ASRS v 1.1 validated in the Ustan et al. (2017) JAMA Psychiatry paper.[3]

The Kooij et al. 2019[4] open access article recommends the DIVA 2 as an interview -- we should add it.

Severity interviews for ADHD

[edit source]
Measure Format (Reporter) Age Range Administration/

Completion Time

Where to Access
Youth
Adults

Note: L = Less than adequate; A = Adequate; G = Good; E = Excellent; U = Unavailable; NA = Not applicable [5]


ICD-11

[edit source]
Latest comment: 7 years ago1 comment1 person in discussion

Should the Diagnosis section also include ICD-11 criteria for Hyperkinetic disorder? —ShelleyAdams (discuss • contribs) 14:09, 5 February 2017 (UTC)Reply

DBD

[edit source]
Latest comment: 6 years ago1 comment1 person in discussion

Pelham wrote a DBD scale that covered DSM-IV symptoms of ADHD, ODD, CD; Waschbush says that it is public domain; worth looking at systematically across the three disorders. If valid, could be worth adding to all three, and also building Wp Page, Wv Page, Qualtrics....

Worth comparing PCARES battery to TOC, chapter recommendations, portfolio list. Eyoungstrom (discuss • contribs) 17:45, 5 October 2018 (UTC)Reply

Summer 2022 Audit

[edit source]
Latest comment: 2 years ago8 comments1 person in discussion

Preparation phase

[edit source]

Diagnostic Criteria of ADHD in youth

[edit source]

Base rates of youth ADHD in different populations and clinical settings

[edit source]

do we need a column for 'best recommended for' if none of them have a check? Hope Holloway (discuss • contribs) 14:32, 13 June 2022 (UTC)Reply

Prediction phase

[edit source]

Psychometric properties of screening instruments for youth ADHD

[edit source]

Screening and diagnostic instruments for attention deficit hyperactivity disorder

[edit source]

do we have the rest of the information to fill out this table? Hope Holloway (discuss • contribs) 14:33, 13 June 2022 (UTC)Reply

Conners 3, Vanderbilt, BASC = top 3

Likelihood ratios and AUCs of screening measures for (insert portfolio name)

[edit source]

need to change this name to include portfolio name Hope Holloway (discuss • contribs) 14:24, 13 June 2022 (UTC) do we need a download column on the table if it's empty? Hope Holloway (discuss • contribs) 14:43, 13 June 2022 (UTC)Reply

Interpreting ADHD screening measure scores

[edit source]

Prescription phase

[edit source]

Gold standard diagnostic interviews

[edit source]

link broken to PDFs Hope Holloway (discuss • contribs) 14:24, 13 June 2022 (UTC)Reply

[edit source]

Taking out adult section and will look in A Guide to Assessments That Work by Hunsley & Mash

Severity interviews for ADHD

[edit source]

need to change depression instrument placeholders Hope Holloway (discuss • contribs) 14:24, 13 June 2022 (UTC) need to remove extra rows on the tables Hope Holloway (discuss • contribs) 14:24, 13 June 2022 (UTC)Reply

Process phase

[edit source]

Process measures

[edit source]

Outcome and severity measures

[edit source]

see here link just leads to table below Hope Holloway (discuss • contribs) 14:24, 13 June 2022 (UTC)Reply

Treatment

[edit source]

last link is external- should this be noted or changed? Hope Holloway (discuss • contribs) 01:48, 14 June 2022 (UTC)Reply

[edit source]

last four links lead to FIU broken page Hope Holloway (discuss • contribs) 14:24, 13 June 2022 (UTC)Reply

References

[edit source]
  1. ↑ Kessler, Ronald C.; Adler, Lenard; Ames, Minnie; Demler, Olga; Faraone, Steve; Hiripi, Eva; Howes, Mary J.; Jin, Robert et al. (2005-02). "The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population". Psychological Medicine 35 (2): 245–256. doi:10.1017/S0033291704002892. ISSN 0033-2917. https://www.cambridge.org/core/product/identifier/S0033291704002892/type/journal_article. 
  2. ↑ Richarte, Vanesa; Corrales, Montserrat; Pozuelo, Marian; Serra-Pla, Juanfran; Ibáñez, Pol; Calvo, Eva; Corominas, Margarida; Bosch, Rosa et al. (2017-10). "Validación al español de la ADHD Rating Scale (ADHD-RS) en adultos: relevancia de los subtipos clínicos". Revista de Psiquiatría y Salud Mental 10 (4): 185–191. doi:10.1016/j.rpsm.2017.06.003. https://linkinghub.elsevier.com/retrieve/pii/S1888989117300897. 
  3. ↑ Ustun, Berk; Adler, Lenard A.; Rudin, Cynthia; Faraone, Stephen V.; Spencer, Thomas J.; Berglund, Patricia; Gruber, Michael J.; Kessler, Ronald C. (2017-05-01). "The World Health Organization Adult Attention-Deficit/Hyperactivity Disorder Self-Report Screening Scale for DSM-5". JAMA Psychiatry 74 (5): 520. doi:10.1001/jamapsychiatry.2017.0298. ISSN 2168-622X. PMID 28384801. PMC PMC5470397. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2616166. 
  4. ↑ Kooij, J.J.S.; Bijlenga, D.; Salerno, L.; Jaeschke, R.; Bitter, I.; Balázs, J.; Thome, J.; Dom, G. et al. (2019). "Updated European Consensus Statement on diagnosis and treatment of adult ADHD". European Psychiatry 56 (1): 14–34. doi:10.1016/j.eurpsy.2018.11.001. ISSN 0924-9338. https://www.cambridge.org/core/product/identifier/S092493380000910X/type/journal_article. 
  5. ↑ "Evidence-based assessment/Reliability - Wikiversity". en.wikiversity.org. Retrieved 2020-11-13.
Retrieved from "https://en.wikiversity.org/w/index.php?title=Talk:Evidence-based_assessment/Attention_deficit_hyperactivity_disorder_(assessment_portfolio)&oldid=2440826"